These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 13184273)

  • 1. [Benign encephalitis after vaccination against yellow fever with a vaccine attenuated in embryonal tissue].
    LARTIGAUT M; COUTEAU
    J Med Bord; 1954 May; 131(5):506-7. PubMed ID: 13184273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Encephalitis in children in Costa Rica and Honduras after Dakar yellow fever vaccination].
    EKLUND CM
    Bol Oficina Sanit Panam; 1953 Nov; 35(5):505-16. PubMed ID: 13105786
    [No Abstract]   [Full Text] [Related]  

  • 3. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.
    Kitchener S
    Vaccine; 2004 Jun; 22(17-18):2103-5. PubMed ID: 15149765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscerotropic disease following yellow fever vaccination in Peru.
    Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E
    Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allergic reaction after yellow fever vaccination].
    BECKER H; LIESKE H
    Z Tropenmed Parasitol; 1957 Mar; 8(1-2):4-7. PubMed ID: 13443402
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute viscerotropic disease following vaccination against yellow fever.
    Hayes EB
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):967-71. PubMed ID: 17669451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever and Japanese encephalitis vaccines: indications and complications.
    Marfin AA; Eidex RS; Kozarsky PE; Cetron MS
    Infect Dis Clin North Am; 2005 Mar; 19(1):151-68, ix. PubMed ID: 15701552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalitis following neurotropic yellow fever vaccine administered by scarification in Nigeria: epidemiological and laboratory studies.
    STONES PB; MACNAMARA FN
    Trans R Soc Trop Med Hyg; 1955 Mar; 49(2):176-86. PubMed ID: 14373854
    [No Abstract]   [Full Text] [Related]  

  • 10. Encephalitis in an infant after vaccination with 17 D yellow fever virus.
    SMITH JH
    Br Med J; 1954 Oct; 2(4892):852. PubMed ID: 13199329
    [No Abstract]   [Full Text] [Related]  

  • 11. Encephalitis in infants following vaccination with 17 D yellow fever virus: report of a further case.
    THOMPSON WO
    Br Med J; 1955 Jul; 2(4932):182-3. PubMed ID: 14389721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of postvaccinal encephalitis in children of different ages after first vaccination].
    BERGER K; PUNTIGAM F
    Wien Med Wochenschr; 1954 Jun; 104(25):487-92. PubMed ID: 13196333
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of the Arilvax; yellow fever vaccine.
    Barrett AD
    Expert Rev Vaccines; 2004 Aug; 3(4):413-20. PubMed ID: 15270646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever-associated viscerotropic disease in Barcelona, Spain.
    Muñoz J; Vilella A; Domingo C; Nicolas JM; de Ory F; Corachan M; Tenorio A; Gascon J
    J Travel Med; 2008; 15(3):202-5. PubMed ID: 18494699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Embolic encephalitis following vaccination in a diabetic].
    DE VRIES E
    Ned Tijdschr Geneeskd; 1954 Sep; 98(36):2478-81. PubMed ID: 13214156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Encephalitis following anti-yellow fever vaccination (from 248 cases observed at Dakar in 1965)].
    Mar ID; Niang I; Guicheney A; Berne C; Collomb H; Rey M; Satgé P
    Ann Pediatr (Paris); 1967 Mar; 14(3):181-91. PubMed ID: 4387264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral manifestations after combined TAB-tetanus-diphtheria vaccination; clinical and electroencephalographic evolution].
    ANDRE-BALISAUX G
    Acta Neurol Psychiatr Belg; 1954 Apr; 54(4):249-61. PubMed ID: 13180282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.